XML 63 R43.htm IDEA: XBRL DOCUMENT v3.19.3
INCENTIVE COMPENSATION (Tables)
9 Months Ended
Sep. 29, 2019
INCENTIVE COMPENSATION [Abstract]  
Schedule of Awards
The following LTIP awards were outstanding during the thirty-nine weeks ended September 29, 2019:
Award Type
 
Awards Granted
 
Grant Date
 
Intended Settlement Method
 
Grant Date Fair Value
per Award
 
Milestone Date Fair Value per Award
 
Vesting Condition
 
Vesting Date
 
Awards Forfeited to Date
RSU
 
410,000

 
2/14/2018
 
Stock
 
$
25.59

 
NA

 
Service
 
1/1/2019
 

RSU
 
163,764

 
3/1/2018
 
Stock
 
24.93

 
NA

 
Service
 
(a)
 
45,755

RSU
 
250,351

 
3/1/2018
 
Stock
 
24.93

 
NA

 
Performance / Service
 
(b)
 
151,229

RSU
 
33,174

 
3/1/2018
 
Cash
 
24.93

 
$
31.31

 
Performance / Service
 
(c)
 

RSU
 
8,358

 
5/10/2018
 
Stock
 
21.54

 
NA

 
Service
 
(d)
 

RSU
 
2,786

 
5/10/2018
 
Cash
 
21.54

 
26.86

 
Service
 
5/1/2019
 

RSU
 
262,500

 
12/18/2018
 
Stock
 
16.06

 
NA

 
Service
 
7/1/2019
 

RSU
 
396,763

 
1/7/2019
 
Stock
 
16.47

 
NA

 
Performance / Service
 
(e)
 
92,075

RSU
 
109,654

 
1/7/2019
 
Cash
 
16.47

 
31.31

 
Performance / Service
 
(f)
 

RSU
 
200,000

 
4/30/2019
 
Stock
 
26.91

 
NA

 
Service
 
7/1/2020
 

RSU
 
11,170

 
5/24/2019
 
Stock
 
27.86

 
NA

 
Service
 
(d)
 

(a)
The restricted stock units vest in ratable tranches on December 31, 2018, December 31, 2019 and December 31, 2020. Expected compensation cost related to these units totals $2.9 million based on a closing stock price for the Company’s common stock of $24.93 per share on March 1, 2018. Compensation cost will be amortized to profit/loss over the remaining vesting period.
(b)
The restricted stock units vest in ratable tranches on December 31, 2019, December 31, 2020 and December 31, 2021. Expected compensation cost related to these units totals $2.5 million based on a closing stock price for the Company’s common stock of $24.93 per share on March 1, 2018. Compensation cost will be amortized to profit/loss over the remaining vesting period.
(c)
The restricted stock units vest in ratable tranches on December 31, 2019, December 31, 2020 and December 31, 2021. Expected compensation cost related to these units totals $1.0 million based on a closing stock price for the Company's common stock of $31.31 per share on September 29, 2019. Compensation cost will be amortized to profit/loss over the remaining vesting period.
(d)
These restricted stock units were granted to the non-employees who currently serve on the Company's Board of Directors. Each participating director's units will vest upon his departure from the Company's Board of Directors. Compensation cost was recognized in profit/loss upon the grant date.
(e)
If performance conditions related to the Company's 2019 operating results are satisfied, the restricted stock units vest in ratable tranches on December 31, 2020, December 31, 2021 and December 31, 2022. Expected compensation cost related to these units totals $5.1 million based on a closing stock price for the Company's common stock of $16.47 per share on January 7, 2019. Compensation cost will be amortized to profit/loss upon satisfaction of the performance conditions over the remaining vesting period.
(f)
If performance conditions related to the Company's 2019 operating results are satisfied, the restricted stock units vest in ratable tranches on December 31, 2020, December 31, 2021 and December 31, 2022. Expected compensation cost related to these units totals $3.4 million based on a closing stock price for the Company's common stock of $31.31 per share on September 29, 2019. Compensation cost will be amortized to profit/loss upon satisfaction of the performance conditions over the remaining vesting period.
Schedule of Compensation Cost and Income Tax Benefit
Compensation costs and the income tax benefit recognized for our share-based compensation arrangements are included below:
 
Thirteen Weeks Ended
 
Thirty-Nine Weeks Ended
 
September 29, 2019
 
September 30, 2018
 
September 29, 2019
 
September 30, 2018
 
(In thousands)
Equity-based awards compensation cost:
 
 
 
 
 
 
 
Cost of sales
$
149

 
$
124

 
$
311

 
$
293

Selling, general and administrative expense
1,956

 
3,502

 
7,011

 
8,966

Total cost
2,105

 
3,626

 
7,322

 
9,259

Income tax benefit
512

 
883

 
1,782

 
2,254

Net cost
$
1,593

 
$
2,743

 
$
5,540

 
$
7,005

 
 
 
 
 
 
 
 
Liability-based awards compensation cost:
 
 
 
 
 
 
 
Selling, general and administrative expense
$
224

 
$

 
$
452

 
$

Income tax benefit
55

 

 
110

 

Net cost
$
169

 
$

 
$
342

 
$


Schedule of Restricted Share and Restricted Stock Unit Activity
The Company’s RSU activity is included below:
 
Thirty-Nine Weeks Ended September 29, 2019
 
Thirty-Nine Weeks Ended September 30, 2018
 
Number
 
Weighted Average Grant Date Fair Value
 
Number
 
Weighted Average Grant Date Fair Value
 
(In thousands, except weighted average fair values)
Equity-based RSUs:
 
 
 
 
 
 
 
Outstanding at beginning of period
1,033

 
$
22.91

 
389

 
$
18.39

Granted
608

 
20.11

 
849

 
25.20

Vested
(721
)
 
22.08

 

 

Forfeited
(227
)
 
21.51

 
(427
)
 
18.97

Outstanding at end of period
693

 
21.79

 
811

 
25.22

 
 
 
 
 
 
 
 
 
Thirty-Nine Weeks Ended September 29, 2019
 
Thirty-Nine Weeks Ended September 30, 2018
 
Number
 
Weighted Average Milestone Date Fair Value(a)
 
Number
 
Weighted Average Milestone Date Fair Value(a)
 
(In thousands, except weighted average fair values)
Liability-based RSUs:
 
 
 
 
 
 
 
Outstanding at beginning of period

 
$

 

 
$

Granted
146

 
16.25

 

 

Vested
(3
)
 
26.86

 

 

Outstanding at end of period
143

 
31.31

 

 


(a)
The milestone date fair value is the closing price of a share of the Company's common stock on the respective milestone date (i.e., grant date, vesting date, forfeiture date or financial reporting date).